ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

BEAM Beam Therapeutics Inc

22.45
0.71 (3.27%)
시간외 단일가
최종 업데이트: 18:00:43
15분 지연
기업명 주식 심볼 시장 주식 타입
Beam Therapeutics Inc BEAM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.71 3.27% 22.45 18:00:43
개장가 저가 고가 종가 전일 종가
21.74
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/03/202419:30GLOBEBeam Therapeutics Announces Clearance of Clinical Trial..
28/02/202420:30GLOBEBeam Therapeutics to Participate in Upcoming March 2024..
27/02/202421:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/02/202421:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202420:43EDGAR2Form 8-K - Current report
27/02/202420:30GLOBEBeam Therapeutics Reports Fourth Quarter and Year-End 2023..
05/02/202420:30GLOBEBeam Therapeutics to Participate in the Guggenheim..
03/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:47EDGAR2Form 144 - Report of proposed sale of securities
08/01/202420:55EDGAR2Form 8-K - Current report
08/01/202420:30GLOBEBeam Therapeutics Highlights Progress Across Base Editing..
06/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202420:30GLOBEBeam Therapeutics to Present at the 42nd Annual J.P. Morgan..
15/12/202306:05EDGAR2Form 8-K - Current report
14/12/202320:30GLOBEBeam Therapeutics Appoints Biotech Executive Christi Shaw to..
21/11/202306:20EDGAR2Form 144 - Report of proposed sale of securities
08/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202321:00EDGAR2Form 8-K - Current report
08/11/202320:30GLOBEBeam Therapeutics Reports Pipeline and Business Updates and..
02/11/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202319:59DJNBeam Therapeutics to Sell Rights in Verve Licensing Deal to..
31/10/202319:44EDGAR2Form 8-K - Current report
31/10/202319:00GLOBEBeam Announces Agreement for Lilly to Acquire Beam’s Opt-In..
31/10/202305:41EDGAR2Form 144 - Report of proposed sale of securities
25/10/202319:30GLOBEBeam Therapeutics Presents Preclinical Data Highlighting..
25/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202321:50EDGAR2Form 8-K - Current report
19/10/202321:45GLOBEBeam Therapeutics Announces Portfolio Prioritization and..
05/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202323:00GLOBEBeam Therapeutics Presents Preclinical Data Highlighting..
05/09/202319:30GLOBEBeam Therapeutics Announces First Patient Dosed in Phase 1/2..
31/08/202319:30GLOBEBeam Therapeutics to Participate in Upcoming September..
10/08/202305:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:11EDGAR2Form 8-K - Current report
08/08/202319:30GLOBEBeam Therapeutics Reports Pipeline Updates and Second..
26/07/202307:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/07/202307:31EDGAR2Form 144 - Report of proposed sale of securities
17/05/202319:30GLOBEBeam Therapeutics to Participate in Upcoming May Investor..
11/05/202319:30GLOBEBeam Therapeutics to Participate in RBC Capital Markets 2023..
10/05/202319:30GLOBEBeam Therapeutics Reports Pipeline Updates and First Quarter..

최근 히스토리

Delayed Upgrade Clock